M. Hubmann

637 total citations
27 papers, 464 citations indexed

About

M. Hubmann is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, M. Hubmann has authored 27 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Biomedical Engineering. Recurrent topics in M. Hubmann's work include Acute Myeloid Leukemia Research (5 papers), Smart Materials for Construction (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). M. Hubmann is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Smart Materials for Construction (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). M. Hubmann collaborates with scholars based in Germany, United Kingdom and Switzerland. M. Hubmann's co-authors include Götz Geldner, K. W. Jacobi, Ralph Knöll, Roland Hardt, M. Schaldach, Jan Braess, Karsten Spiekermann, Thomas Köhnke, Marion Subklewe and A Dufour and has published in prestigious journals such as Social Science & Medicine, Leukemia and Age and Ageing.

In The Last Decade

M. Hubmann

22 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hubmann Germany 11 226 94 86 50 47 27 464
Yasuhiro Kuroda Japan 12 50 0.2× 13 0.1× 88 1.0× 37 0.7× 24 0.5× 75 548
Alison M. Graham United States 11 21 0.1× 9 0.1× 73 0.8× 48 1.0× 48 1.0× 18 261
Richard A. Larsen United States 9 219 1.0× 26 0.3× 59 0.7× 24 0.5× 63 1.3× 15 979
Elizabeth H. Danish United States 11 284 1.3× 14 0.1× 76 0.9× 11 0.2× 282 6.0× 23 583
Jianru Wang China 22 13 0.1× 93 1.0× 188 2.2× 52 1.0× 10 0.2× 58 1.2k
Walter Muir United States 15 491 2.2× 24 0.3× 109 1.3× 33 0.7× 392 8.3× 22 958
J.C. Hewlett United States 7 7 0.0× 31 0.3× 88 1.0× 14 0.3× 17 0.4× 9 530
Gutteridge Jean-Charles United States 13 27 0.1× 25 0.3× 79 0.9× 17 0.3× 19 0.4× 26 281
Mitsuhiro Sato Japan 13 74 0.3× 16 0.2× 78 0.9× 20 0.4× 11 0.2× 60 918

Countries citing papers authored by M. Hubmann

Since Specialization
Citations

This map shows the geographic impact of M. Hubmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hubmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hubmann more than expected).

Fields of papers citing papers by M. Hubmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hubmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hubmann. The network helps show where M. Hubmann may publish in the future.

Co-authorship network of co-authors of M. Hubmann

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hubmann. A scholar is included among the top collaborators of M. Hubmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hubmann. M. Hubmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spooner, Sharon, et al.. (2024). The hidden work of general practitioners: An ethnography. Social Science & Medicine. 350. 116922–116922. 5 indexed citations
4.
Rothenberg‐Thurley, Maja, Thomas Köhnke, Nikola P. Konstandin, et al.. (2017). Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia. Leukemia. 9 indexed citations
5.
Fritsch, Susanne, Dušan Prevalšek, Nicole Engel, et al.. (2015). Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation. 50(5). 679–684. 16 indexed citations
6.
Hubmann, M., Thomas Köhnke, Eva Hoster, et al.. (2014). Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse. Haematologica. 99(8). 1317–1325. 72 indexed citations
7.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2014). Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplantation. 49(7). 895–901. 32 indexed citations
8.
Köhnke, Thomas, Eva Hoster, M. Hubmann, et al.. (2014). Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse. Leukemia. 29(2). 377–386. 50 indexed citations
10.
Ammatuna, Emanuele, Pau Montesinos, Syed K. Hasan, et al.. (2010). Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis. Haematologica. 96(4). 621–625. 14 indexed citations
11.
Waschgler, R., et al.. (2002). Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 554–559. 32 indexed citations
12.
Hubmann, M., et al.. (2000). The integration of the baroceptor reflex into the rate regulation of Closed Loop Stimulation. Herzschrittmachertherapie + Elektrophysiologie. 11(3). 184–191. 1 indexed citations
13.
Geldner, Götz, M. Hubmann, Ralph Knöll, & K. W. Jacobi. (1997). Comparison between three transmucosal routes of administration of midazolam in children. Pediatric Anesthesia. 7(2). 103–109. 66 indexed citations
14.
Hubmann, M., et al.. (1995). 41 SIMULTANEOUS DRUG MONITORING OF CITALOPRAM, CLOZAPINE, FLUOXETINE, MAPROTILINE, AND TRAZODONE IN SERUM BY HPLC ANALYSIS. Therapeutic Drug Monitoring. 17(4). 393–393. 1 indexed citations
15.
Bolz, A., et al.. (1993). Low polarization pacing lead for detecting the ventricular-evoked response.. PubMed. 19(3). 129–37. 21 indexed citations
16.
Hubmann, M., Roland Hardt, A. Bolz, & M. Schaldach. (1992). Long-term performance of stimulation and sensing behaviour of TiN and Ir coated pacemaker leads having a fractal surface structure. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2379–2380. 3 indexed citations
17.
Hubmann, M., et al.. (1989). Bewegungsenergie als Steuergröße für die Anpassung der Stimulationsfrequenz - Motion Energy as a Control Variable for Sensor-Driven Rate Adaptation. Biomedizinische Technik/Biomedical Engineering. 34(7-8). 191–196. 4 indexed citations
18.
Hubmann, M.. (1979). Polarization processes in the ice lattice. The European Physical Journal B. 32(2). 127–139. 31 indexed citations
19.
Hubmann, M.. (1978). Effect of Pressure on the Dielectric Properties of Ice Ih Single Crystals Doped with NH3 and HF. Journal of Glaciology. 21(85). 161–172. 3 indexed citations
20.
Hubmann, M., et al.. (1977). [Systolic periods in dependence of age].. PubMed. 32(6). 509–17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026